In the face of increased scrutiny of medical device companies and continued enforcement activities against both medical device and pharmaceutical companies, ACI’s 17th Annual Conference on Fraud and Abuse in the Sale and Marketing of Drugs, Devices, and Medical Technology will once again provide a forum unlike any other for legal and compliance professionals to engage with government enforcers and network with peers.
WHY THIS YEAR’S EVENT IS MUST-ATTEND FOR YOU AND YOUR TEAM
- In addition to 11 government speakers from multiple jurisdiction, NEW this year is a Keynote Address from the FDA’s Associate Chief Counsel for Enforcement, Beth P. Weinman.
- Developed by attorneys and compliance professionals, each session has been tailored to be both practical and forward thinking, with an emphasis on best practices for preventing and defending against these potentially monumental prosecutions. Featured sessions this year will specifically help you to reduce the risk of claims under the FCA, Anti-Kickback, and FCPA, as well as criminal prosecutions, fines, and negative publicity.
- Network and brainstorm with compliance professionals and general counsel from Acumed, Bayer Corporation, Biogen, Cantel Medical Corp., ConvaTec, Hill-Rom, Medtronic, OMNI, Otsuka Pharmaceutical, Upsher-Smith Laboratories, Inc., Vertex Pharmaceuticals, and others. Hear their experiences on how they are managing under constant government oversight, how they are integrating government guidance into their compliance protocols and staff training programs, and what lessons they have learned from the latest decisions and settlements.